A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)Stefano Cascinu, Giuseppina Catalano, Claudio Graiff et al.|Annals of Oncology|2000Cited by 36